Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan (original) (raw)

Investigation of in-vitro susceptibility of multidrug-resistant Acinetobacter baumannii strains isolated from clinical specimens to tigecycline

Şeyda Özsoy Karabörk

Bosnian Journal of Basic Medical Sciences, 2013

View PDFchevron_right

Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp

Raúl O. de Lejarazu

Journal of Antimicrobial Chemotherapy, 2009

View PDFchevron_right

In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia

Mahmoud Shorman, Ghulam Dhabaan

Journal of Chemotherapy, 2012

View PDFchevron_right

Major Variation in MICs of Tigecycline in Gram-Negative Bacilli as a Function of Testing Method

Hossein Salimnia

Journal of Clinical Microbiology, 2014

View PDFchevron_right

Emergence of Tigecycline Resistant Acinetobacter baumannii from an Intensive Care Unit (ICU) in Tehran

A. Salmanian

Jundishapur Journal of Microbiology, 2013

View PDFchevron_right

Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans

Aleksandra Smitran

Acta Microbiologica et Immunologica Hungarica, 2020

View PDFchevron_right

Agreement Assessment of Tigecycline Susceptibilities Determined by the Disk Diffusion and Broth Microdilution Methods among Commonly Encountered Resistant Bacterial Isolates: Results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) Study, 2008 to 2010

Po-ren Hsueh, Ming-hsun Lee

Antimicrobial Agents and Chemotherapy, 2012

View PDFchevron_right

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii

Silvia D'Arezzo

Annals of Clinical Microbiology and Antimicrobials, 2009

View PDFchevron_right

AN IN-VITRO STUDY OF TIGECYCLINE SUSCEPTIBILITY AMONG MULTIDRUG RESISTANT BACTERIA IN A TERTIARY CARE HOSPITAL

Scholar Science Journals

View PDFchevron_right

Trends in the Susceptibility of Clinically Important Resistant Bacteria to Tigecycline: Results from the Tigecycline In Vitro Surveillance in Taiwan Study, 2006 to 2010

Ming-hsun Lee

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii

Shiri Navon-venezia

Journal of Antimicrobial Chemotherapy, 2007

View PDFchevron_right

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

David Wareham

Journal of Antimicrobial Chemotherapy, 2009

View PDFchevron_right

In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline

martha mushi

Journal of Antimicrobial Chemotherapy, 2012

View PDFchevron_right

Tigecycline Susceptibility of Carbapenem Resistant Enterobacteriaceae and Acinetobacter spp. isolates from Respiratory Tract: A Tertiary Care Centre Study

Prachala Rathod

Journal of Krishna Institute of Medical Sciences University, 2020

View PDFchevron_right

Comparative Evaluation of Tigecycline Susceptibility Testing Methods for Expanded-Spectrum Cephalosporin- and Carbapenem-Resistant Gram-Negative Pathogens

O. Zarkotou

Journal of Clinical Microbiology, 2012

View PDFchevron_right

In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran

parivash davoodian

Electronic physician

View PDFchevron_right

Comparison of Disk Diffusion and E-Test with the Reference Method of Microbroth Dilution for Susceptibility Testing of Acinetobacter baumannii Isolates to Tetracyclines

Medical Laboratory Journal MLJ

Medical Laboratory Journal, 2016

View PDFchevron_right

Susceptibility to Tigecycline of Multiresistant Bacteria at Ibn Rochd University Hospital-Casablanca

assiya el kettani

2019

View PDFchevron_right

Activity of Tigecycline (GAR936) against Acinetobacter baumannii Strains, Including Those Resistant to Imipenem

maria eugenia

Antimicrobial Agents and Chemotherapy, 2004

View PDFchevron_right

Rapid Development of Acinetobacter baumannii Resistance to Tigecycline

Nina Clark, Shellee Grim

Pharmacotherapy, 2007

View PDFchevron_right

In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy

Stefania Stefani

Annals of Clinical Microbiology and Antimicrobials, 2008

View PDFchevron_right

Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: Results of the Ege study

Alper Sener

Clinical neurology and neurosurgery, 2018

View PDFchevron_right

Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum β-lactamase-producing Enterobacteriaceae

Wu Sun

International Journal of Antimicrobial Agents, 2008

View PDFchevron_right

Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

Despoina Koulenti

Journal of Antimicrobial Chemotherapy, 2006

View PDFchevron_right

In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South Africa

Cornelis Clay

BMC Research Notes, 2012

View PDFchevron_right